ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,00%
Bitcoin
60.856,06
0,10%
Brent Oil
82,585
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aptose Biosciences Inc (APTO)

  7. Aptose Biosciences Inc (APTO) Notícias

APTO

Aptose Biosciences (APTO)

Aptose Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:APTO
DataHoraFonteTítuloCódigoCompanhia
10/05/202412:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
06/05/202417:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
14/02/202418:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APTOAptose Biosciences Inc
26/01/202419:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APTOAptose Biosciences Inc
26/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APTOAptose Biosciences Inc
25/01/202423:44Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:APTOAptose Biosciences Inc
19/01/202423:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
09/11/202319:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
21/09/202318:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APTOAptose Biosciences Inc
06/07/202317:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:APTOAptose Biosciences Inc
26/06/202317:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTOAptose Biosciences Inc
20/06/202307:01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APTOAptose Biosciences Inc
19/04/202307:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APTOAptose Biosciences Inc
03/04/202317:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APTOAptose Biosciences Inc
24/03/202307:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTOAptose Biosciences Inc
14/02/202319:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTOAptose Biosciences Inc
17/01/202308:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APTOAptose Biosciences Inc
12/12/202213:55TipRanksJonesTrading Keeps Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
17/11/202211:55TipRanksAptose Biosciences (APTO) Gets a Buy from H.C. WainwrightNASDAQ:APTOAptose Biosciences Inc
02/11/202208:45TipRanksJonesTrading Remains a Buy on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
02/11/202207:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
01/11/202217:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTOAptose Biosciences Inc
24/10/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APTOAptose Biosciences Inc
21/10/202218:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:APTOAptose Biosciences Inc
11/10/202207:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:APTOAptose Biosciences Inc
21/09/202219:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTOAptose Biosciences Inc
03/08/202209:22TipRanksJonesTrading Thinks Aptose Biosciences’ Stock is Going to RecoverNASDAQ:APTOAptose Biosciences Inc
03/08/202208:21TipRanksCanaccord Genuity Thinks Aptose Biosciences’ Stock is Going to RecoverNASDAQ:APTOAptose Biosciences Inc
03/08/202207:26TipRanksH.C. Wainwright Thinks Aptose Biosciences’ Stock is Going to RecoverNASDAQ:APTOAptose Biosciences Inc
28/06/202217:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APTOAptose Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:APTO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
YDUQ3
ESTACIO PART ON
BOV
UNIP6
UNIPAR PNB
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados